Clinical Trials Directory

Assessment and Treatment of Cognitive Deficits in Breast Cancer

RATIONALE: Breast cancer and its treatment may cause changes in a patient's ability to think, learn, and remember. Gathering information about a woman's genes, brain function, and personal history may help doctors learn more about the disease and plan the best treatment. PURPOSE: 1. To determine changes in brain function that occur following breast cancer chemotherapy. 2. To gain further understanding of the individual differences in brain function changes and recovery based on demographic, medical and treatment variables.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • behavioral : Cognitive Rehabilitation
  • behavioral : Neurofeedback Training (randomized)
  • behavioral : Neuropsychological testing and MRI assessments

Phase: Phase 1


Ages Eligible For Study:

40 Years - 65 Years

Inclusion Criteria

3.1.1 Primary, non-metastatic breast cancer 3.1.2 Newly diagnosed patients who have not yet begun treatment. 3.1.4 Female participants age 40-65 years of all ethnicities who speak fluent English will be recruited. 3.1.5 There are no life expectancy restrictions. 3.1.6 Karnofsky Performance Status 70% minimum. ECOG will not be employed. 3.1.7 There are no requirements for marrow function. The brain must be free from gross neuropathology and metastases in order to participate. 3.1.8 Ability to understand and the willingness to sign a written informed consent document.

External Links

Explore related trials

Contact information

Primary Contact:

Shelli Kesler, PhD 650-723-0058

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: